Anti‑chondrocyte apoptosis effect of genistein in treating inflammation‑induced osteoarthritis
Authors:
Open Access
- 18 June 2020
- journal article
- research article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 22 (3) , 2032-2042
Abstract
Osteoarthritis (OA) is a chronic disease that is mainly characterized by chondrocyte degeneration. Inflammatory mediators participate in the development of OA, leading to chondrocyte apoptosis and destruction of the cartilage. Genistein is the major active component of isoflavone, with a chemical composition and a biological effect that is similar to that of estrogens, which prevents the degradation of cartilage; however, its underlying mechanisms of action remain unknown. The aim of the present study was to investigate the anti‑apoptotic effects of genistein on chondrocytes for the treatment of inflammation‑induced OA. Interleukin (IL)‑1β was used to establish a chondrocyte OA model. After treatment with different concentrations of genistein, western blotting identified that expression levels of collagen II and aggrecan were increased in a concentration‑dependent manner, while caspase 3 expression gradually decreased after genistein application. Moreover, flow cytometry and ELISA results demonstrated that genistein could decrease chondrocyte apoptosis and reduce the levels of tumor necrosis factor (TNF)‑α in a dose‑dependent manner. Furthermore, the in vitro data were evaluated in an OA rat model. Genistein increased the collagen and acid glycosaminoglycan content, as well as decreased the levels of TNF‑α and IL‑1β. Genistein also promoted the expression levels of collagen II and aggrecan in the articular cartilage, and decreased the expression of caspase 3, thus alleviating cartilage degradation. In conclusion, the results indicated that genistein mediated inflammation and had an anti‑apoptotic role in treating OA. Therefore, genistein may serve as an alternative treatment for OA.Keywords
This publication has 50 references indexed in Scilit:
- Genistein Sensitizes Bladder Cancer Cells to HCPT Treatment In Vitro and In Vivo via ATM/NF-κB/IKK Pathway-Induced ApoptosisPLOS ONE, 2013
- Isoflavones: estrogenic activity, biological effect and bioavailabilityEuropean Journal of Drug Metabolism and Pharmacokinetics, 2012
- Chondroprotective and anti‐inflammatory role of melanocortin peptides in TNF‐α activated human C‐20/A4 chondrocytesBritish Journal of Pharmacology, 2012
- Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damageOsteoarthritis and Cartilage, 2012
- Age and sexually dimorphic changes in costal cartilages. A preliminary microscopic studyForensic Science International, 2009
- Stromal Cell-Derived Factor-1 Induces Matrix Metalloprotease-13 Expression in Human ChondrocytesMolecular Pharmacology, 2007
- Pharmacological studies of the large-scaled purified genistein from Huaijiao (Sophora japonica – Leguminosae) on anti-osteoporosisPhytomedicine, 2006
- Effect of genistein on the expression of bone metabolism genes in ovariectomized mice using a cDNA microarrayThe Journal of Nutritional Biochemistry, 2006
- Association of repeat polymorphisms in the estrogen receptors α, β, and androgen receptor genes with knee osteoarthritisClinical Genetics, 2005
- Role of interleukin‐1 and tumor necrosis factor α in matrix degradation of human osteoarthritic cartilageArthritis & Rheumatism, 2005